IRIDEX CORP (IRIX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
28/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseIRIX / S&P 13.86% / 15.20% |
LoseIRIX / S&P 3.68% / 15.00% |
LoseIRIX / S&P -39.39% / 50.40% |
| 2026-Q10/3 |
LoseIRIX / S&P -11.40% / -4.33% |
LoseIRIX / S&P 7.73% / 11.30% |
LoseIRIX / S&P -55.81% / 27.70% |
| 2025-Q40/3 |
LoseIRIX / S&P 0.00% / 2.65% |
LoseIRIX / S&P 8.23% / 9.00% |
LoseIRIX / S&P -51.85% / 13.40% |
| 2025-Q31/3 |
WinIRIX / S&P 29.55% / 8.12% |
LoseIRIX / S&P 4.58% / 4.61% |
LoseIRIX / S&P -55.22% / 13.45% |
| 2025-Q20/3 |
LoseIRIX / S&P -11.11% / 10.94% |
LoseIRIX / S&P 0.09% / 4.83% |
LoseIRIX / S&P -50.00% / 10.63% |
| 2025-Q10/3 |
LoseIRIX / S&P -41.07% / -4.27% |
LoseIRIX / S&P -2.24% / 4.98% |
LoseIRIX / S&P -35.82% / 10.57% |
| 2024-Q40/3 |
LoseIRIX / S&P -4.00% / 2.41% |
LoseIRIX / S&P -6.17% / 5.25% |
LoseIRIX / S&P -8.47% / 6.15% |
| 2024-Q31/3 |
LoseIRIX / S&P -18.98% / 5.89% |
LoseIRIX / S&P -11.31% / 5.89% |
WinIRIX / S&P 39.58% / 6.11% |
| 2024-Q21/3 |
LoseIRIX / S&P -27.52% / 4.28% |
LoseIRIX / S&P -11.87% / 5.38% |
WinIRIX / S&P 37.50% / 5.12% |
| 2024-Q11/3 |
LoseIRIX / S&P 6.05% / 10.56% |
LoseIRIX / S&P -12.86% / 5.71% |
WinIRIX / S&P 48.89% / 5.59% |
| 2023-Q41/3 |
LoseIRIX / S&P 10.63% / 11.69% |
LoseIRIX / S&P -8.96% / 6.81% |
WinIRIX / S&P 25.53% / 7.78% |
| 2023-Q31/3 |
WinIRIX / S&P 17.05% / -3.27% |
LoseIRIX / S&P -4.25% / 7.52% |
LoseIRIX / S&P -14.29% / -5.03% |
| 2023-Q20/3 |
LoseIRIX / S&P 6.90% / 8.74% |
LoseIRIX / S&P 1.31% / 9.50% |
LoseIRIX / S&P -18.64% / -8.57% |
| 2023-Q11/3 |
LoseIRIX / S&P 1.00% / 7.50% |
LoseIRIX / S&P 3.54% / 10.77% |
WinIRIX / S&P 25.00% / -15.69% |
| 2022-Q41/3 |
LoseIRIX / S&P -16.60% / 7.56% |
LoseIRIX / S&P 5.69% / 11.88% |
WinIRIX / S&P 34.29% / -17.99% |
| 2022-Q31/3 |
LoseIRIX / S&P -6.23% / -4.88% |
LoseIRIX / S&P 11.93% / 13.47% |
WinIRIX / S&P 166.67% / -1.41% |
| 2022-Q22/3 |
LoseIRIX / S&P -44.49% / -16.10% |
WinIRIX / S&P 19.72% / 13.71% |
WinIRIX / S&P 210.53% / 11.04% |
| 2022-Q11/3 |
LoseIRIX / S&P -24.22% / -4.60% |
WinIRIX / S&P 40.85% / 15.97% |
LoseIRIX / S&P -25.00% / 42.23% |
| 2021-Q41/3 |
LoseIRIX / S&P -20.23% / 11.03% |
WinIRIX / S&P 48.30% / 15.00% |
LoseIRIX / S&P -23.91% / 96.40% |
| 2021-Q32/3 |
WinIRIX / S&P 8.50% / 0.58% |
WinIRIX / S&P 42.31% / 10.77% |
LoseIRIX / S&P -61.82% / 69.42% |
| 2021-Q21/3 |
LoseIRIX / S&P 4.59% / 8.55% |
WinIRIX / S&P 23.43% / 6.58% |
LoseIRIX / S&P -66.07% / 51.81% |
| 2021-Q11/3 |
WinIRIX / S&P 168.92% / 6.17% |
LoseIRIX / S&P -6.18% / -1.06% |
LoseIRIX / S&P -11.11% / 7.39% |
| 2020-Q42/3 |
WinIRIX / S&P 28.06% / 12.15% |
LoseIRIX / S&P -16.34% / -3.72% |
WinIRIX / S&P -28.13% / -33.42% |
| 2020-Q31/3 |
LoseIRIX / S&P -7.55% / 8.93% |
LoseIRIX / S&P -17.03% / -2.04% |
WinIRIX / S&P -24.66% / -27.10% |
| 2020-Q21/3 |
WinIRIX / S&P 33.33% / 20.54% |
LoseIRIX / S&P -14.02% / -0.46% |
LoseIRIX / S&P -34.88% / -27.11% |
| 2020-Q10/3 |
LoseIRIX / S&P -28.70% / -19.60% |
LoseIRIX / S&P -4.15% / 3.47% |
LoseIRIX / S&P -43.75% / -14.75% |
| 2019-Q41/3 |
WinIRIX / S&P 20.54% / 9.07% |
LoseIRIX / S&P 1.99% / 5.36% |
LoseIRIX / S&P -39.05% / 2.99% |
| 2019-Q30/3 |
LoseIRIX / S&P -59.34% / 1.70% |
LoseIRIX / S&P 4.29% / 5.02% |
LoseIRIX / S&P -43.41% / 0.21% |
| 2019-Q21/3 |
LoseIRIX / S&P -0.22% / 4.30% |
WinIRIX / S&P 7.06% / 6.64% |
LoseIRIX / S&P -33.85% / 8.65% |
| 2019-Q10/3 |
LoseIRIX / S&P -2.98% / 13.65% |
LoseIRIX / S&P 7.55% / 8.12% |
LoseIRIX / S&P -23.81% / 14.29% |
| 2018-Q40/3 |
LoseIRIX / S&P -25.98% / -13.52% |
LoseIRIX / S&P 2.42% / 9.05% |
LoseIRIX / S&P -5.41% / 18.23% |
| 2018-Q30/3 |
LoseIRIX / S&P -8.76% / 7.71% |
LoseIRIX / S&P -5.71% / 10.21% |
LoseIRIX / S&P -25.43% / 19.06% |
| 2018-Q21/3 |
WinIRIX / S&P 21.68% / 3.43% |
LoseIRIX / S&P -4.40% / 9.03% |
LoseIRIX / S&P -15.03% / 14.46% |
| 2018-Q10/3 |
LoseIRIX / S&P -24.93% / -0.76% |
LoseIRIX / S&P -9.15% / 7.68% |
LoseIRIX / S&P -4.55% / 12.46% |
| 2017-Q40/3 |
LoseIRIX / S&P -18.68% / 6.64% |
LoseIRIX / S&P -9.89% / 7.03% |
LoseIRIX / S&P -3.48% / 13.82% |
| 2017-Q31/3 |
LoseIRIX / S&P -5.26% / 4.48% |
LoseIRIX / S&P -4.07% / 5.68% |
WinIRIX / S&P 4225.00% / 17.57% |
| 2017-Q20/3 |
LoseIRIX / S&P -16.68% / 3.09% |
LoseIRIX / S&P -6.47% / 4.83% |
LoseIRIX / S&P -2285.71% / 17.74% |
| 2017-Q11/3 |
LoseIRIX / S&P -15.58% / 6.07% |
WinIRIX / S&P 4.24% / 3.67% |
LoseIRIX / S&P -4500.00% / 13.32% |
| 2016-Q41/3 |
LoseIRIX / S&P -2.97% / 3.82% |
WinIRIX / S&P 10.54% / 2.09% |
LoseIRIX / S&P -2975.00% / 7.05% |
| 2016-Q31/3 |
LoseIRIX / S&P -2.03% / 3.85% |
WinIRIX / S&P 10.43% / 0.20% |
LoseIRIX / S&P -104.76% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | IRIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.01% | 20.78% |
| Annualized return | -47.01% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | IRIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.08% | 83.14% |
| Annualized return | -37.01% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | IRIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.23% | 319.30% |
| Annualized return | -26.23% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |